JANXJanux Therapeutics, Inc.
$18.51-18% 1Y
$18.51
$12.1852 weeks$34.74
What is the market doing?
Good
1 good, 2 without dataIn an uptrend. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendUptrendderived · Oct 8, 2026
In an uptrend, above its rising 50- and 200-day averages. Price is +23% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How JANX is trading
Janux Therapeutics, Inc. is −18% over the past year while the S&P 500 is +18%: 37 points behind the market.
−18%
1-year return · S&P 500 +18%
- vs 200-day average
- +23%
vs 200-day average · a clear uptrend
- RSI (14)
- 66
RSI (14) · neutral
- Below its 52-week high
- 47%
Below its 52-week high
Details›
- Last close2026-10-08
- $18.51
- 1 monthS&P 500 +1.6%
- −4.2%
- 1 yearS&P 500 +18%
- −18%
- 5 yearsS&P 500 +86%
- −14%
- vs 50-day average$17.26
- +7.3%
- 52-week high
- $34.74
- 52-week low
- $12.18
- Annualised volatility
- 76%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$86K
| Year | Return |
|---|---|
| 2026 (year to date) | +34% |
| 2025 | −74% |
| 2024 | +399% |
| 2023 | −19% |
| 2022 | −33% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 1 of 5 | +1.2% |
| Feb | 5 | 2 of 5 | +86% |
| Mar | 5 | 1 of 5 | −16% |
| Apr | 5 | 4 of 5 | +15% |
| May | 5 | 2 of 5 | −8.8% |
| Jun | 5 | 3 of 5 | −1.5% |
| Jul | 6 | 4 of 6 | +8.2% |
| Aug | 6 | 3 of 6 | +0.19% |
| Sep | 6 | 2 of 6 | −3.4% |
| Oct | 6 | 5 of 6 | +8.9% |
| Nov | 5 | 2 of 5 | −2.6% |
| Dec | 5 | 3 of 5 | −2.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.